Cargando…
P19 An audit to improve ENT SHO confidence in using Floseal in the management of epistaxis
BACKGROUND: Departmental guidelines regarding the management of epistaxis were adapted to deal with the additional challenges presented during the Covid-19 pandemic. One of these adjustments involved the increasing use of haemostatic sealants such as Floseal in the management of epistaxis allowing r...
Autores principales: | Ringrose, T, Crossley, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8030251/ http://dx.doi.org/10.1093/bjsopen/zrab032.018 |
Ejemplares similares
-
P15 Admission avoidance in acute epistaxis: a prospective national audit during the initial peak of the COVID-19 pandemic
Publicado: (2021) -
Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
por: Lee, John M., et al.
Publicado: (2019) -
Management of Persistent Epistaxis Using Floseal Hemostatic Matrix vs. traditional nasal packing: a prospective randomized control trial
por: Murray, Scott, et al.
Publicado: (2018) -
Audit of strategies to improve sepsis management in emergency departments
por: Thakker, CE, et al.
Publicado: (2015) -
HPV infection in ENT - certainties and assumptions
por: Mitran, Loredana, et al.
Publicado: (2013)